BCX9930 for the Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH) in Participants Not Receiving Other Complement Inhibitor Therapy

PHASE2TerminatedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 26, 2021

Primary Completion Date

September 18, 2023

Study Completion Date

September 18, 2023

Conditions

Paroxysmal Nocturnal Hemoglobinuria (PNH)

Interventions

DRUG

Placebo

Administered orally twice daily

DRUG

BCX9930 monotherapy

Administered orally twice daily

Trial Locations (5)

Investigative Site, Ampang

Investigative Site, Bloemfontein

Investigative Site, Cape Town

Investigative Site, Pretoria

InvestigativeSite, Daejeon